Treatment of autoimmune arthritis by oral administration of type I or type III collagen
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 31, 1998
Grant Date -
N/A
app pub date -
Jun 2, 1995
filing date -
Jun 24, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention is directed to a method of treating a T cell-mediated autoimmune disease in animals, including humans, by the oral administration of autoantigens, fragments of autoantigens, or analogs structurally related to those autoantigens, which are specific for the particular autoimmune disease. The method of the invention includes both prophylactic and therapeutic measures.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully